Champions Oncology (CSBR) Competitor Comparison
We are evaluating the key criteria listed to compare Champions Oncology (CSBR) against its competitors in the Biotechnology industry.
Market Capitalization
275 / 368Gross Profits
83 / 278Total Revenue
121 / 300EBITDA
44 / 337Free Cashflow
42 / 352Quick Ratio
341 / 357Earnings per Share
61 / 359Dividend yield
0 / 6Total Cash
334 / 358Performance 3 years
176 / 368Performance 5 years
148 / 368Performance 10 years
145 / 368Linearity 3 years
97 / 368Linearity 5 years
26 / 368Linearity 10 years
74 / 368Total Rank
23 / 368Dividend Rank
28 / 368Valuation Rank
171 / 368Piotroski Rank
6 / 368Muliplier Rank
101 / 368Performance 5 years - CSBR ranking 148 / 368
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.